批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2023/04/28 |
SUPPL-21(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2023/04/28 |
SUPPL-19(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2023/04/28 |
SUPPL-16(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2023/04/28 |
SUPPL-15(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2021/06/22 |
SUPPL-13(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2021/06/22 |
SUPPL-12(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2021/06/22 |
SUPPL-11(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2021/06/22 |
SUPPL-10(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2021/06/22 |
SUPPL-9(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2021/06/22 |
SUPPL-8(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2015/10/23 |
SUPPL-2(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2015/10/23 |
SUPPL-1(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2012/05/30 |
ORIG-1(原始申请) |
Approval |
|
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
无 |
与本品治疗等效的药品
活性成分:VORICONAZOLE 剂型/给药途径:INJECTABLE;INTRAVENOUS 规格:200MG/VIAL 治疗等效代码:AP
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
021267 |
001 |
NDA |
VFEND |
VORICONAZOLE |
INJECTABLE;INTRAVENOUS |
200MG/VIAL |
Prescription |
Yes |
Yes |
AP |
2002/05/24
|
PF PRISM CV |
090862 |
001 |
ANDA |
VORICONAZOLE |
VORICONAZOLE |
INJECTABLE;INTRAVENOUS |
200MG/VIAL |
Prescription |
No |
No |
AP |
2012/05/30
|
SANDOZ INC |
206398 |
001 |
ANDA |
VORICONAZOLE |
VORICONAZOLE |
INJECTABLE;INTRAVENOUS |
200MG/VIAL |
Prescription |
No |
No |
AP |
2016/03/23
|
ALMAJECT |
208562 |
001 |
NDA |
VORICONAZOLE |
VORICONAZOLE |
INJECTABLE;INTRAVENOUS |
200MG/VIAL |
Prescription |
No |
No |
AP |
2017/03/09
|
CHARTWELL RX |
208983 |
001 |
ANDA |
VORICONAZOLE |
VORICONAZOLE |
INJECTABLE;INTRAVENOUS |
200MG/VIAL |
Prescription |
No |
No |
AP |
2018/07/16
|
ZYDUS PHARMS |
211661 |
001 |
ANDA |
VORICONAZOLE |
VORICONAZOLE |
INJECTABLE;INTRAVENOUS |
200MG/VIAL |
Prescription |
No |
No |
AP |
2018/11/30
|
SLATE RUN PHARMA |
211099 |
001 |
ANDA |
VORICONAZOLE |
VORICONAZOLE |
INJECTABLE;INTRAVENOUS |
200MG/VIAL |
Prescription |
No |
No |
AP |
2020/03/31
|
GLAND PHARMA LTD |
214516 |
001 |
ANDA |
VORICONAZOLE |
VORICONAZOLE |
INJECTABLE;INTRAVENOUS |
200MG/VIAL |
Prescription |
No |
No |
AP |
2022/05/09
|
MEITHEAL |
210849 |
001 |
ANDA |
VORICONAZOLE |
VORICONAZOLE |
INJECTABLE;INTRAVENOUS |
200MG/VIAL |
Discontinued |
No |
No |
AP |
2022/10/11
|
NORVIUM BIOSCIENCE |
212162 |
001 |
ANDA |
VORICONAZOLE |
VORICONAZOLE |
INJECTABLE;INTRAVENOUS |
200MG/VIAL |
Discontinued |
No |
No |
AP |
2023/02/02
|
EUGIA PHARMA |
211264 |
001 |
ANDA |
VORICONAZOLE |
VORICONAZOLE |
INJECTABLE;INTRAVENOUS |
200MG/VIAL |
Prescription |
No |
No |
AP |
2023/03/09
|
UBI |
218533 |
001 |
ANDA |
VORICONAZOLE |
VORICONAZOLE |
INJECTABLE;INTRAVENOUS |
200MG/VIAL |
Prescription |
No |
No |
AP |
2024/04/03
|
ASPIRO |